An expanded matrix of sizes for the GliderXtreme PTA balloon catheter has received clearance from the US Food and Drug Administration (FDA).

GliderXtreme, developed by TriReme Medical, can treat percutaneous transluminal of lesions in the peripheral vasculature in balloon diameters from 2mm to 5mm and lengths of up to 200mm.

GliderXtreme is used to treat patients with complex vascular disease, which affects approximately 12 million Americans and leads to chronic pain, significant mobility limitations and decreasing quality of life.

GliderXtreme’s configuration allows exceptional push, even in very long balloons.

GliderXtreme combined with a traumatic tapered tip and shaft construction reinforced for torque transmission can cross distal, long, tight lesions to restore blood flow in complex peripheral anatomy.